Your session is about to expire
← Back to Search
Orthopedic Implant
APEX Modular for Osteoarthritis
N/A
Waitlist Available
Led By David F Scott, MD
Research Sponsored by Spokane Joint Replacement Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 weeks, 6 months, 1, 2, 3, 4, and 5 years post-operative
Awards & highlights
No Placebo-Only Group
Summary
This study compares the change in bone density which occurs after hip replacement with different femoral stem devices.
Eligible Conditions
- Osteoarthritis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 6 weeks, 6 months, 1, 2, 3, 4, and 5 years post-operative
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 weeks, 6 months, 1, 2, 3, 4, and 5 years post-operative
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Femoral bone mineral density
Secondary study objectives
Harris Hip Score (HHS)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: ARC StemExperimental Treatment1 Intervention
ARC Stem group
Group II: APEX ModularExperimental Treatment1 Intervention
APEX Modular Stem group
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
OMNI Apex ARC™ Hip Device
2009
N/A
~80
OMNI Apex Modular™ Hip Device
2009
N/A
~80
Find a Location
Who is running the clinical trial?
Spokane Joint Replacement CenterLead Sponsor
5 Previous Clinical Trials
10,276 Total Patients Enrolled
3 Trials studying Osteoarthritis
10,194 Patients Enrolled for Osteoarthritis
David F Scott, MDPrincipal InvestigatorSpokane Joint Replacement Center
3 Previous Clinical Trials
294 Total Patients Enrolled
3 Trials studying Osteoarthritis
294 Patients Enrolled for Osteoarthritis
Share this study with friends
Copy Link
Messenger